Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Peanuts (Arachis hypogaea) are being investigated by Penn State University for their impact on glycemic control and the gut microbiome. In a clinical trial setting, roasted, unsalted peanuts are administered to individuals with impaired fasting glucose to determine if their consumption, particularly in the evening, improves blood glucose regulation compared to high-carbohydrate snacks. The therapeutic potential is thought to derive from the peanut's composition of fiber, monounsaturated fatty acids, and bioactive polyphenols, which may slow glucose absorption and promote a beneficial microbial environment in the gut.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on peanut.